Effectiveness and safety of an injectable-free shorter regimen for Rifampicin resistant and Multidrug Resistant Tuberculosis treatment in Rusafa District, Baghdad, IRAQ
-
Location
-
Topic
-
Methodology
-
ReferenceOCB020-1899
Purpose of study
Purpose of study
-
Concept
-
Protocol & ERB
-
Implementation
-
Completion
-
Archived
Study timeline
-
Publication added by Petros Isaakidis
4th May 2023 -
Protocol added by Petros Isaakidis
10th February 20202019.02.25_Injectable-free_DRTB_protocol_IRAQ_V9.5_Ethics_Clean_F.docx411 KB -
ERB documentation added by Petros Isaakidis
10th February 2020MSF_ERB_approval_protocol_1899_26Feb19.pdf125 KB
Publications
-
Introduction of new drugs for drug-resistant TB in IraqTesfahun, H. "–" International Union Against Tuberculosis and Lung Disease "(2021)"
Previous study
Next study